REVB, REVBW · CIK 0001810560 · operating
REVELATION BIOSCIENCES, INC. (REVBW) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. The stock currently trades at $0.01, up 1.10% today, with a 52-week range of $0.01–$0.01.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-23.95 | $-23.95 | +72.7% | |
| 2024 | $-87.68 | $-87.68 | -16443.4% | |
| 2023 | $-0.53 | $-0.53 | +97.4% | |
| 2022 | $-20.09 | $-20.09 | -1617.1% | |
| 2021 | — | $-1.17 | — | |
| 2020 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001193125-26-076552 | SEC ↗ |
| 2024-12-31 | 2025-03-06 | 0000950170-25-034584 | SEC ↗ |
| 2023-12-31 | 2024-03-22 | 0000950170-24-035322 | SEC ↗ |
| 2022-12-31 | 2023-03-30 | 0000950170-23-011000 | SEC ↗ |
| 2021-12-31 | 2022-04-15 | 0001213900-22-020179 | SEC ↗ |
| 2020-12-31 | 2021-03-31 | 0001213900-21-019097 | SEC ↗ |